review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1097/00006454-200302001-00006 |
P698 | PubMed publication ID | 12671451 |
P2093 | author name string | H Cody Meissner | |
P433 | issue | 2 Suppl | |
P304 | page(s) | S40-4; discussion S44-5 | |
P577 | publication date | 2003-02-01 | |
P1433 | published in | Pediatric Infectious Disease Journal | Q15756717 |
P1476 | title | Selected populations at increased risk from respiratory syncytial virus infection | |
P478 | volume | 22 |
Q40117278 | A critical role of Gas6/Axl signal in allergic airway responses during RSV vaccine-enhanced disease |
Q38837433 | Advancing our understanding of infant bronchiolitis through phenotyping and endotyping: clinical and molecular approaches. |
Q34313560 | Animal pneumoviruses: molecular genetics and pathogenesis |
Q36523253 | Antimicrobial therapy in childhood asthma and wheezing. |
Q40191355 | Associations of Nasopharyngeal Metabolome and Microbiome with Severity Among Infants with Bronchiolitis: A Multi-omic Analysis |
Q59354281 | Bronchiolitis in children: The Saudi initiative of bronchiolitis diagnosis, management, and prevention (SIBRO) |
Q22241278 | Epidemiology and etiology of childhood pneumonia |
Q40287752 | Epidemiology of 11 respiratory RNA viruses in a cohort of hospitalized children in Riyadh, Saudi Arabia |
Q40283024 | Epidemiology of respiratory virus infections among infants and young children admitted to hospital in Oman. |
Q42210332 | Etiology of acute bronchiolitis and the relationship with meteorological conditions in hospitalized infants in China |
Q35950212 | Excess soluble vascular endothelial growth factor receptor-1 in amniotic fluid impairs lung growth in rats: linking preeclampsia with bronchopulmonary dysplasia |
Q34120191 | Gene expression differences in lungs of mice during secondary immune responses to respiratory syncytial virus infection. |
Q24202303 | Glucocorticoids for acute viral bronchiolitis in infants and young children |
Q35857662 | Host transcription profiles upon primary respiratory syncytial virus infection |
Q45417824 | Human metapneumovirus infections cause similar symptoms and clinical severity as respiratory syncytial virus infections |
Q40430519 | Human respiratory syncytial virus and other viral infections in infants receiving palivizumab |
Q40043100 | Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines |
Q91910118 | Improving Evidence Based Bronchiolitis Care |
Q39442518 | Incidence of Respiratory Disease During the First Two Years of Life in Children with Hemodynamically Significant Congenital Heart Disease in Italy: A Retrospective Study |
Q45394767 | Medical retrieval and needs of infants with bronchiolitis: an analysis by gestational age. |
Q47271049 | Nebulised hypertonic saline solution for acute bronchiolitis in infants. |
Q27002560 | Recent advances in management of bronchiolitis |
Q36145000 | Reducing the impact of viral respiratory infections in children |
Q35526996 | Respiratory Syncytial Virus Prophylaxis in Special Populations: Is it Something Worth Considering in Cystic Fibrosis and Immunosuppression? |
Q38694691 | Respiratory syncytial virus (RSV) entry is inhibited by serine protease inhibitor AEBSF when present during an early stage of infection. |
Q36361899 | Respiratory syncytial virus bronchiolitis |
Q45399642 | Respiratory syncytial virus infection in 406 hospitalized premature infants: results from a prospective German multicentre database |
Q40298671 | Respiratory syncytial virus infection in children with neuromuscular impairment |
Q38968287 | Respiratory syncytial virus infections in Central Australia. |
Q33591243 | Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology |
Q24655957 | Respiratory viruses other than influenza virus: impact and therapeutic advances |
Q90109697 | Risk factors for bronchiolitis hospitalization in infants: A French nationwide retrospective cohort study over four consecutive seasons (2009-2013) |
Q54265000 | Risk factors for severe bronchiolitis caused by respiratory virus infections among Mexican children in an emergency department. |
Q37669850 | Safety, Tolerability, and Pharmacokinetics of MEDI8897, the Respiratory Syncytial Virus Prefusion F-Targeting Monoclonal Antibody with an Extended Half-Life, in Healthy Adults |
Q33312377 | Sensitive commercial NASBA assay for the detection of respiratory syncytial virus in clinical specimen |
Q26766723 | Stable long-term cultures of self-renewing B cells and their applications |
Q33952463 | Systemic signature of the lung response to respiratory syncytial virus infection |
Q36411968 | Treatment of respiratory virus infections |
Search more.